Answers are grounded in this paper and cite their sources.
Review demonstrates AI advancements in drug design and target identification for Traditional Chinese Medicine, highlighting implications for clinical practice.
Traditional Chinese medicine (TCM) achieves therapeutic effects through multi-component and multi-target regulation, but its complexity makes mechanistic interpretation and rational prescription optimization difficult. The rapid growth of chemical structure data, multi-omics profiles, and large-scale clinical records has facilitated data-driven TCM research, although it also presents significant analytical challenges. Artificial intelligence (AI) offers a solution to this data-to-knowledge gap. This review covers recent progress in AI-driven TCM research, from active ingredient and target discovery to mechanism elucidation and intelligent prescription recommendations. We highlight AI-assisted compound screening and structure-based target prediction, integration of multi-omics data and knowledge graphs (KGs) for network inference, and AI-based prediction of synergistic drug combinations and formula optimization. Finally, we discuss key challenges related to data quality, interpretability, robustness, and clinical translation, along with future directions in AI-driven TCM research.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: